265 related articles for article (PubMed ID: 24080298)
41. Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer.
Caon J; Holloway C; Dubash R; Yuen C; Aquino-Parsons C
Brachytherapy; 2014; 13(1):94-9. PubMed ID: 24269147
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
[TBL] [Abstract][Full Text] [Related]
43. Comparison of dosimetric and clinical outcomes between short- and long-channel cylinder applicators for vaginal brachytherapy in intermediate- and high-risk endometrial cancer.
Kharouta MZ; Pham N; Nieto K; Surucu M; Mysz ML; Albuquerque K; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
Brachytherapy; 2018; 17(4):673-679. PubMed ID: 29759329
[TBL] [Abstract][Full Text] [Related]
44. Dosimetric impact of interfraction catheter movement and organ motion on MRI/CT guided HDR interstitial brachytherapy for gynecologic cancer.
Rey F; Chang C; Mesina C; Dixit N; Kevin Teo BK; Lin LL
Radiother Oncol; 2013 Apr; 107(1):112-6. PubMed ID: 23333023
[TBL] [Abstract][Full Text] [Related]
45. Salvage high-dose-rate brachytherapy for isolated vaginal recurrence of endometrial cancer.
Baek S; Isohashi F; Yamaguchi H; Mabuchi S; Yoshida K; Kotsuma T; Yamazaki H; Tanaka E; Sumida I; Tamari K; Otani K; Seo Y; Suzuki O; Yoshioka Y; Kimura T; Ogawa K
Brachytherapy; 2016; 15(6):812-816. PubMed ID: 27614661
[TBL] [Abstract][Full Text] [Related]
46. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer.
Kirisits C; Lang S; Dimopoulos J; Oechs K; Georg D; Pötter R
Radiother Oncol; 2006 Dec; 81(3):269-75. PubMed ID: 17126938
[TBL] [Abstract][Full Text] [Related]
47. Point A vs. HR-CTV D
Harmon G; Diak A; Shea SM; Yacoub JH; Small W; Harkenrider MM
Brachytherapy; 2016; 15(6):825-831. PubMed ID: 27693173
[TBL] [Abstract][Full Text] [Related]
48. Image-guided tandem and cylinder brachytherapy as monotherapy for definitive treatment of inoperable endometrial carcinoma.
Gebhardt B; Gill B; Glaser S; Kim H; Houser C; Kelley J; Sukumvanich P; Edwards R; Comerci J; Olawaiye A; Courtney-Brooks M; Boisen M; Berger J; Beriwal S
Gynecol Oncol; 2017 Nov; 147(2):302-308. PubMed ID: 28923412
[TBL] [Abstract][Full Text] [Related]
49. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
50. Multi-channel intracavitary vaginal brachytherapy using three-dimensional optimization of source geometry.
Tanderup K; Lindegaard JC
Radiother Oncol; 2004 Jan; 70(1):81-5. PubMed ID: 15036856
[TBL] [Abstract][Full Text] [Related]
51. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
52. A Dosimetric evaluation of a high dose rate cobalt-60 brachytherapy source using shielded, single and multi-channel cylinder applicators for gynecological cancers.
Abtahi M; Safaei AM; Sheikhzade P; Gholami S
Med Dosim; 2022 Winter; 47(4):318-324. PubMed ID: 35907692
[TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of rectal dose parameters in image-guided high-dose-rate brachytherapy for cervical cancer with and without a rectal retractor.
Gaudet M; Lim P; Yuen C; Zhang S; Spadinger I; Dubash R; Aquino-Parsons C
Brachytherapy; 2014; 13(3):257-62. PubMed ID: 24480263
[TBL] [Abstract][Full Text] [Related]
54. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
55. Outcomes with image-based interstitial brachytherapy for vaginal cancer.
Manuel MM; Cho LP; Catalano PJ; Damato AL; Miyamoto DT; Tempany CM; Schmidt EJ; Viswanathan AN
Radiother Oncol; 2016 Sep; 120(3):486-492. PubMed ID: 27321150
[TBL] [Abstract][Full Text] [Related]
56. Comparison of CT-based volumetric dosimetry with traditional prescription points in the treatment of cervical cancer with PDR brachytherapy.
Lowrey N; Nilsson S; Moutrie Z; Chan P; Cheuk R
J Med Imaging Radiat Oncol; 2015 Oct; 59(5):640-5. PubMed ID: 26223554
[TBL] [Abstract][Full Text] [Related]
57. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of a 3D-printed applicator for vaginal brachytherapy in patients with central pelvic-recurrent cervical cancer after primary hysterectomy.
Qin X; Zhang F; Hou X; Yu L; Yu L; Yan J; Qiu J
Brachytherapy; 2022; 21(2):193-201. PubMed ID: 34980568
[TBL] [Abstract][Full Text] [Related]
59. Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.
Nesseler JP; Charra-Brunaud C; Salleron J; Py JF; Huertas A; Meknaci E; Courrech F; Peiffert D; Renard-Oldrini S
Brachytherapy; 2017; 16(5):976-980. PubMed ID: 28694116
[TBL] [Abstract][Full Text] [Related]
60. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
